CS-622 DURATION OF ACTION IN MILD TO MODERATE ESSENTIAL HYPERTENSION

CS-622 轻度至中度原发性高血压的作用持续时间

• 批准号: 3849160
• 负责人: JACKSON T WRIGHT
• 金额: --
• 依托单位: UNIVERSITY HOSPITALS OF CLEVELAND
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3849160
• 关键词: ACE inhibitors; azepines; cardiovascular disorder chemotherapy; dosage; drug screening /evaluation; human subject; human therapy evaluation; hypertension; pharmacokinetics; placebos

The purpose of this study was to assess the safety, tolerability, and duration of action of the investigational angiotensin converting enzyme inhibitor, CS-622, in patients with mild to moderate essential hypertension. This was a double-blind, placebo controlled, ascending dose, parallel study with an initial single-blind placebo period.

本研究的目的是评估其安全性、耐受性和安全性